Prelude Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-13,300
Closed -$127K 1697
2021
Q3
$127K Hold
13,300
﹤0.01% 1117
2021
Q2
$128K Hold
13,300
﹤0.01% 1162
2021
Q1
$131K Sell
13,300
-16,408
-55% -$162K ﹤0.01% 980
2020
Q4
$686K Sell
29,708
-5,348
-15% -$123K 0.02% 287
2020
Q3
$495K Sell
35,056
-7,616
-18% -$108K 0.02% 294
2020
Q2
$643K Buy
+42,672
New +$643K 0.04% 231
2019
Q4
Sell
-1,820
Closed -$15K 1526
2019
Q3
$15K Buy
+1,820
New +$15K ﹤0.01% 969
2019
Q2
Sell
-584
Closed -$8K 1399
2019
Q1
$8K Buy
+584
New +$8K ﹤0.01% 1129
2018
Q4
Sell
-158,281
Closed -$1.91M 1503
2018
Q3
$1.91M Buy
158,281
+80,200
+103% +$970K 0.11% 138
2018
Q2
$1.22M Sell
78,081
-49,618
-39% -$775K 0.08% 203
2018
Q1
$1.92M Buy
127,699
+78,851
+161% +$1.19M 0.14% 110
2017
Q4
$703K Sell
48,848
-23,952
-33% -$345K 0.06% 287
2017
Q3
$1.1M Sell
72,800
-209,899
-74% -$3.17M 0.1% 198
2017
Q2
$2.85M Sell
282,699
-31,170
-10% -$314K 0.27% 70
2017
Q1
$2.24M Sell
313,869
-12,587
-4% -$89.8K 0.21% 104
2016
Q4
$1.62M Buy
326,456
+65,146
+25% +$324K 0.2% 128
2016
Q3
$1.93M Buy
261,310
+255,610
+4,484% +$1.89M 0.2% 94
2016
Q2
$31K Buy
+5,700
New +$31K ﹤0.01% 1104
2016
Q1
Sell
-6,800
Closed -$66K 1261
2015
Q4
$66K Sell
6,800
-3,200
-32% -$31.1K 0.01% 899
2015
Q3
$140K Buy
10,000
+5,500
+122% +$77K 0.02% 673
2015
Q2
$64K Buy
+4,500
New +$64K 0.01% 986
2015
Q1
Sell
-3,500
Closed -$29K 1914
2014
Q4
$29K Sell
3,500
-2,000
-36% -$16.6K ﹤0.01% 1542
2014
Q3
$33K Buy
+5,500
New +$33K ﹤0.01% 1492